{"id":"https://openalex.org/W4411286558","doi":"https://doi.org/10.1158/1557-3265.sabcs24-lb1-06","title":"Abstract LB1-06: Primary results of SOLTI VALENTINE: neoadjuvant randomized phase II trial of HER3-DXd alone or in combination with letrozole for high-risk hormone receptor positive (HR+)/HER2-negative (neg) early breast cancer (EBC)","display_name":"Abstract LB1-06: Primary results of SOLTI VALENTINE: neoadjuvant randomized phase II trial of HER3-DXd alone or in combination with letrozole for high-risk hormone receptor positive (HR+)/HER2-negative (neg) early breast cancer (EBC)","publication_year":2025,"publication_date":"2025-06-13","ids":{"openalex":"https://openalex.org/W4411286558","doi":"https://doi.org/10.1158/1557-3265.sabcs24-lb1-06"},"language":"en","primary_location":{"id":"doi:10.1158/1557-3265.sabcs24-lb1-06","doi":"https://doi.org/10.1158/1557-3265.sabcs24-lb1-06","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1557-3265.sabcs24-lb1-06","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5053983312","display_name":"Mafalda Oliveira","orcid":"https://orcid.org/0000-0001-9152-8799","observed_orcids":["https://orcid.org/0000-0001-9152-8799"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mafalda Oliveira","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043895722","display_name":"Tom\u00e1s Pascual","orcid":"https://orcid.org/0000-0001-8431-3183","observed_orcids":["https://orcid.org/0000-0001-8431-3183"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tom\u00e1s Pascual","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045092640","display_name":"Kepa Amillano Parraga","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kepa Amillano Parraga","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053044048","display_name":"Javier Salvador Bofill","orcid":"https://orcid.org/0000-0003-3043-4398","observed_orcids":["https://orcid.org/0000-0003-3043-4398"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Javier Salvador Bofill","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071667052","display_name":"Santiago Gonz\u00e1lez-Santiago","orcid":"https://orcid.org/0000-0002-4787-0236","observed_orcids":["https://orcid.org/0000-0002-4787-0236"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Santiago Gonz\u00e1lez-Santiago","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004474804","display_name":"Clara Mart\u00ednez-Vila","orcid":"https://orcid.org/0000-0002-9775-2166","observed_orcids":["https://orcid.org/0000-0002-9775-2166"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Clara Mart\u00ednz Vila","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103463851","display_name":"Josefina Cruz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Josefina Cruz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025842545","display_name":"Xavier Gonz\u00e1lez","orcid":"https://orcid.org/0000-0002-5797-7037","observed_orcids":["https://orcid.org/0000-0002-5797-7037"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xavier Gonz\u00e1lez-Farr\u00e9","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082177784","display_name":"Elena Galve-Calvo","orcid":"https://orcid.org/0000-0003-4204-5736","observed_orcids":["https://orcid.org/0000-0003-4204-5736"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elena Galve","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040940175","display_name":"Pilar S\u00e1nchez Henar\u00e9jos","orcid":"https://orcid.org/0000-0003-1280-3313","observed_orcids":["https://orcid.org/0000-0003-1280-3313"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pilar S\u00e1nchez Henarejos","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015289835","display_name":"Juan Miguel Cejalvo","orcid":"https://orcid.org/0000-0002-8755-8626","observed_orcids":["https://orcid.org/0000-0002-8755-8626"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Juan Miguel Cejalvo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022954554","display_name":"Maria-Eva P\u00e9rez-Lopez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maria-Eva P\u00e9rez-Lopez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113688022","display_name":"Montse Mu\u00f1oz","orcid":"https://orcid.org/0000-0001-7772-1437","observed_orcids":["https://orcid.org/0000-0001-7772-1437"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Montse Mu\u00f1oz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085797367","display_name":"Serafin M. Morales","orcid":"https://orcid.org/0000-0001-7445-4193","observed_orcids":["https://orcid.org/0000-0001-7445-4193"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Serafin Morales","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046498505","display_name":"Alba Gonz\u00e1lez-Haba","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alba Gonz\u00e1lez-Haba","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042046620","display_name":"M. Borrell Puy","orcid":"https://orcid.org/0000-0002-6059-677X","observed_orcids":["https://orcid.org/0000-0002-6059-677X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maria Borrell Puy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050828329","display_name":"Encarnaci\u00f3n Gonz\u00e1lez\u2010Flores","orcid":"https://orcid.org/0000-0002-2077-5060","observed_orcids":["https://orcid.org/0000-0002-2077-5060"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Encarnaci\u00f3n Gonz\u00e1lez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032293249","display_name":"Juan Antonio Guerra","orcid":"https://orcid.org/0000-0003-1295-8008","observed_orcids":["https://orcid.org/0000-0003-1295-8008"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Juan A. Guerra","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Sergio Hoyos","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sergio Hoyos","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011090752","display_name":"Antonia Perell\u00f3","orcid":"https://orcid.org/0000-0002-5273-8467","observed_orcids":["https://orcid.org/0000-0002-5273-8467"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Antonia Perell\u00f3","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Pablo Tolosa Ortega","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pablo Tolosa Ortega","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040158829","display_name":"Juan de la Haba-Rodr\u00edguez","orcid":"https://orcid.org/0000-0001-5111-1702","observed_orcids":["https://orcid.org/0000-0001-5111-1702"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Juan De la Haba","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091948864","display_name":"Yenlik Zheteyava","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yenlik Zheteyava","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019334319","display_name":"David Sternberg","orcid":"https://orcid.org/0000-0002-3925-1304","observed_orcids":["https://orcid.org/0000-0002-3925-1304"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David W. Sternberg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059656244","display_name":"Fumitaka Suto","orcid":"https://orcid.org/0009-0009-5649-2650","observed_orcids":["https://orcid.org/0009-0009-5649-2650"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fumitaka Suto","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Esther Pang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Esther Pang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064899437","display_name":"Dalila B. Sellami","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dalila Sellami","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045644790","display_name":"Rodrigo S\u00e1nchez-Bayona","orcid":"https://orcid.org/0000-0002-5255-6620","observed_orcids":["https://orcid.org/0000-0002-5255-6620"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rodrigo S\u00e1nchez-Bayona","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028946644","display_name":"Guillermo Javierre Villacampa","orcid":"https://orcid.org/0000-0003-4868-6585","observed_orcids":["https://orcid.org/0000-0003-4868-6585"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Guillermo Villacampa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5096170099","display_name":"Samyukta Chillara","orcid":"https://orcid.org/0000-0002-6072-5455","observed_orcids":["https://orcid.org/0000-0002-6072-5455"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Samyukta Chillara","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004368493","display_name":"Mariana Paes Dias","orcid":"https://orcid.org/0000-0002-5757-4211","observed_orcids":["https://orcid.org/0000-0002-5757-4211"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mariana Paes Dias","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032305758","display_name":"Juan Manuel Ferrero-Cafiero","orcid":"https://orcid.org/0000-0001-8796-8812","observed_orcids":["https://orcid.org/0000-0001-8796-8812"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Juan M. Ferrero-Cafiero","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5089513581","display_name":"Aleix Prat","orcid":"https://orcid.org/0000-0003-2377-540X","observed_orcids":["https://orcid.org/0000-0003-2377-540X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aleix Prat","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"31","issue":"12_Supplement","first_page":"LB1","last_page":"06"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9692000150680542,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9692000150680542,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.0215000007301569,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.004600000102072954,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neoadjuvant-therapy","display_name":"neoadjuvant therapy","score":0.8669999837875366},{"id":"https://openalex.org/keywords/hormone-receptor-positive-breast-cancer","display_name":"hormone receptor-positive breast cancer","score":0.8410000205039978},{"id":"https://openalex.org/keywords/her2-negative-breast-cancer","display_name":"HER2-negative breast cancer","score":0.9829999804496765},{"id":"https://openalex.org/keywords/letrozole","display_name":"letrozole","score":0.9610000252723694},{"id":"https://openalex.org/keywords/gnrh-agonist","display_name":"GnRH agonist","score":0.7559999823570251},{"id":"https://openalex.org/keywords/pathological-complete-response","display_name":"pathological complete response","score":0.6359999775886536},{"id":"https://openalex.org/keywords/residual-cancer-burden","display_name":"residual cancer burden","score":0.6010000109672546},{"id":"https://openalex.org/keywords/ki-67","display_name":"Ki-67","score":0.6129999756813049},{"id":"https://openalex.org/keywords/early-breast-cancer","display_name":"early breast cancer","score":0.6480000019073486},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.7480000257492065},{"id":"https://openalex.org/keywords/endocrine-therapy","display_name":"endocrine therapy","score":0.6520000100135803}],"concepts":[{"id":"https://openalex.org/C2778812593","wikidata":"https://www.wikidata.org/wiki/Q194974","display_name":"Letrozole","level":5,"score":0.753799557685852},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.743970513343811},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5535014867782593},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5454607009887695},{"id":"https://openalex.org/C23589133","wikidata":"https://www.wikidata.org/wiki/Q412005","display_name":"Hormone receptor","level":4,"score":0.45559194684028625},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.32796692848205566},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2655984163284302},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.22348710894584656},{"id":"https://openalex.org/C2777176818","wikidata":"https://www.wikidata.org/wiki/Q412178","display_name":"Tamoxifen","level":4,"score":0.06004485487937927}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1557-3265.sabcs24-lb1-06","doi":"https://doi.org/10.1158/1557-3265.sabcs24-lb1-06","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1557-3265.sabcs24-lb1-06","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4376613757","https://openalex.org/W4410463773","https://openalex.org/W4229003500","https://openalex.org/W3132723614","https://openalex.org/W4220832323","https://openalex.org/W4376613634","https://openalex.org/W7129433182","https://openalex.org/W2806524570","https://openalex.org/W4402407658","https://openalex.org/W4393989122"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Despite":[2],"the":[3,16,24,490,573,583,717],"activity":[4,41,584],"of":[5,18,53,87,140,209,227,236,243,247,256,314,401,450,549,576,585,686,694,716],"both":[6],"chemotherapy":[7],"(CT)":[8],"and":[9,60,149,196,201,211,278,291,323,329,348,361,363,368,374,429,457,475,494,499,523,589],"endocrine":[10],"treatment":[11,223,471,530,596],"in":[12,42,63,93,225,325,339,345,352,370,380,389,394,399,404,409,414,425,434,440,469,489,496,513,538,587,698],"high-risk":[13,599,703],"HR+/HER2-neg":[14,67,108,600],"EBC,":[15],"risk":[17,100],"recurrence":[19],"persists":[20],"over":[21],"time,":[22],"highlighting":[23],"need":[25],"for":[26,124,162,207,598,702],"additional":[27],"strategies":[28],"to":[29,220,231,265,271,385,453,463,503,542,560,564],"improve":[30],"outcome.":[31],"HER3-DXd":[32,54,88,116,128,272,274,390,491,586,695],"is":[33,79],"a":[34,50,80,233,241,245,253,445,546,595],"potential":[35,592],"first-in-class":[36],"HER3-directed":[37],"antibody-drug":[38],"conjugate":[39],"with":[40,57,66,95,137,316,422,531,533,558,700],"multiple":[43],"breast":[44,601,710],"cancer":[45,182,711],"subtypes.":[46],"In":[47,527],"SOLTI":[48,76,528,687],"TOT-HER3,":[49],"single":[51],"dose":[52],"was":[55,168,217,283,309,320,335,358,365,387,476],"associated":[56,421],"increased":[58],"CelTIL":[59,189,381,400,417,553],"clinical":[61],"response":[62,171,186,210,424,559],"patients":[64],"(pts)":[65],"EBC":[68,588],"(Oliveira":[69],"et":[70],"al,":[71],"Ann":[72],"Oncol":[73],"2023).":[74],"Methods:":[75],"VALENTINE":[77],"(NCT05569811)":[78],"parallel,":[81],"randomized,":[82],"non-comparative,":[83],"open-label":[84],"neoadjuvant":[85,689],"study":[86],"+/-":[89],"LET":[90,131,276],"or":[91,145,154,534,697],"CT":[92,136,279],"pts":[94,268,295,315],"operable":[96],"stage":[97],"II-III":[98],"high":[99,105],"(Ki67":[101],"\u2265":[102],"20%":[103],"and/or":[104],"genomic":[106],"risk)":[107],"EBC.":[109],"Pts":[110],"were":[111,205,269,289,467,486,516],"randomized":[112,270,690],"2:2:1":[113],"to:":[114],"(A)":[115],"5.6":[117],"mg/kg":[118],"every":[119],"(Q)":[120],"21":[121,155],"days":[122],"(D)":[123],"6":[125],"cycles;":[126],"(B)":[127],"plus":[129],"QD":[130],"(+/-":[132],"LHRH":[133],"agonist);":[134],"(C)":[135],"4":[138],"cycles":[139],"EC/AC":[141],"(epirubicin":[142],"90":[143],"mg/m2":[144,148,152],"doxorubicin":[146],"60":[147],"cyclophosphamide":[150],"600":[151],"Q14":[153],"D)":[156],"followed":[157],"by":[158],"weekly":[159],"paclitaxel":[160],"80mg/m2":[161],"12":[163],"weeks.":[164],"The":[165,214,332,355,507,566],"primary":[166],"endpoint":[167],"pathological":[169],"complete":[170],"(pCR,":[172],"ypT0/is":[173],"ypN0)":[174],"rate":[175,187,334,357],"at":[176,419,473,479,555],"surgery.":[177,480],"Secondary":[178],"endpoints":[179],"included":[180],"residual":[181],"burden":[183],"(RCB),":[184],"overall":[185,197],"(ORR),":[188],"score":[190,382,456,554],"change,":[191],"safety,":[192],"invasive":[193],"disease-free":[194],"survival,":[195],"survival.":[198],"Baseline,":[199],"C2D1,":[200,474],"surgical":[202],"tissue":[203],"samples":[204],"collected":[206],"evaluation":[208],"translational":[212,568],"endpoints.":[213],"sample":[215],"size":[216],"not":[218,393,433,563],"selected":[219],"formally":[221],"compare":[222],"arms":[224,472,492],"terms":[226],"pCR":[228,242,333,540],"rate,":[229],"but":[230,392,432,562],"achieve":[232],"certain":[234],"level":[235],"precision":[237,254],"estimating":[238],"pCR.":[239],"Assuming":[240],"20%,":[244],"total":[246],"48":[248],"per":[249],"arm":[250],"would":[251],"provide":[252,579],"estimation":[255],"+-11.3%":[257],"using":[258],"asymptotic":[259],"two-sided":[260],"95%CI.":[261],"Results:":[262],"From":[263],"Nov-2022":[264],"Sep-2023,":[266],"122":[267],"(n=50),":[273],"+":[275],"(n=48)":[277],"(n=24).":[280],"Median":[281],"age":[282],"51":[284],"(29":[285],"-":[286],"82),":[287],"99.2%":[288],"females,":[290],"52.9%":[292],"pre/perimenopausal.":[293],"Most":[294],"had":[296],"T2":[297],"(54.1%),":[298],"N1":[299],"(70.5%),":[300],"Stage":[301,317],"II":[302,692],"(64.0%),":[303],"G2":[304],"(69.0%)":[305],"tumors;":[306],"median":[307,397],"Ki67":[308],"35.0%":[310],"(18.0;":[311],"90.0).":[312],"Proportion":[313],"III":[318],"tumors":[319],"36.0%,":[321],"39.5%":[322],"29.2%":[324],"Arms":[326,371,497,514],"A,":[327,341,372,406],"B,":[328,347,373,500],"C,":[330,375],"respectively.":[331,376],"4.0%":[336],"(95%CI":[337,343,350],"0.5-13.7)":[338],"Arm":[340,346,353,395,405,410,415,426,435,504],"2.1%":[342],"0.1-11.1)":[344],"4.2%":[349],"0.1-21.1)":[351],"C.":[354,416],"RCB0/1":[356],"18.4%,":[359],"12.5%":[360],"30.4%,":[362],"ORR":[364],"72.0%,":[366],"81.3%,":[367],"70.8%,":[369],"A":[377,427,438,498],"significant":[378],"change":[379,418],"from":[383,447,458],"baseline":[384],"C2D1":[386,420,556],"observed":[388,468],"arms,":[391],"C:":[396],"increase":[398],"8.2":[402],"(p<0.0001)":[403,428],"7.4":[407],"(p=0.001)":[408],"Band":[411],"3.8":[412],"(p=0.13)":[413],"radiological":[423],"B":[430,461],"(p=0.002),":[431],"C":[436,505],"(p=0.30).":[437],"decrease":[439],"Ki67,":[441],"as":[442,444,570,572,594],"well":[443,571],"switch":[446],"PAM50":[448,459],"Risk":[449],"Recurrence":[451],"(ROR)-high/medium":[452],"ROR-":[454],"low":[455],"Luminal":[460,464],"subtype":[462],"A/Normal-like":[465],"subtypes":[466],"all":[470],"further":[477,580],"enhanced":[478],"Treatment-emergent":[481],"adverse":[482],"events":[483],"(TEAEs)":[484],"grade\u22653":[485],"less":[487],"frequent":[488],"(18.0%":[493],"16.7%":[495],"respectively),":[501],"compared":[502],"(54.2%).":[506],"most":[508],"common":[509],"related":[510],"TEAEs":[511],"reported":[512],"A/B":[515],"nausea":[517],"(56%/72.9%),":[518],"alopecia":[519],"(52%/68.8%),":[520],"fatigue":[521],"(50%/68.8%),":[522],"diarrhea":[524],"(42%/54.2%).":[525],"Conclusions:":[526],"VALENTINE,":[529,577],"HER3-DXd,":[532,561],"without":[535],"LET,":[536],"resulted":[537],"similar":[539],"rates":[541],"CT,":[543],"while":[544],"exhibiting":[545],"lower":[547],"incidence":[548],"grade":[550],"\u22653":[551],"TEAEs.":[552],"correlated":[557],"CT.":[565],"ongoing":[567],"analysis,":[569],"survival":[574],"outcomes":[575],"will":[578],"insights":[581],"into":[582],"clarify":[590],"its":[591],"role":[593],"strategy":[597],"cancer.":[602],"Citation":[603],"Format:":[604],"Mafalda":[605],"Oliveira,":[606],"Tom\u00e1s":[607],"Pascual,":[608],"Kepa":[609],"Amillano":[610],"Parraga,":[611],"Javier":[612],"Salvador":[613],"Bofill,":[614],"Santiago":[615],"Gonz\u00e1lez-Santiago,":[616],"Clara":[617],"Mart\u00ednz":[618],"Vila,":[619],"Josefina":[620],"Cruz,":[621],"Xavier":[622],"Gonz\u00e1lez-Farr\u00e9,":[623],"Elena":[624],"Galve,":[625],"Pilar":[626],"S\u00e1nchez":[627],"Henarejos,":[628],"Juan":[629,645,655,679],"Miguel":[630],"Cejalvo,":[631],"Maria-Eva":[632],"P\u00e9rez-Lopez,":[633],"Montse":[634],"Mu\u00f1oz,":[635],"Serafin":[636],"Morales,":[637],"Alba":[638],"Gonz\u00e1lez-Haba,":[639],"Maria":[640],"Borrell":[641],"Puy,":[642],"Encarnaci\u00f3n":[643],"Gonz\u00e1lez,":[644],"A.":[646],"Guerra,":[647],"Sergio":[648],"Hoyos,":[649],"Antonia":[650],"Perell\u00f3,":[651],"Pablo":[652],"Tolosa":[653],"Ortega,":[654],"De":[656],"la":[657],"Haba,":[658],"Yenlik":[659],"Zheteyava,":[660],"David":[661],"W.":[662],"Sternberg,":[663],"Fumitaka":[664],"Suto,":[665],"Esther":[666],"Pang,":[667],"Dalila":[668],"Sellami,":[669],"Rodrigo":[670],"S\u00e1nchez-Bayona,":[671],"Guillermo":[672],"Villacampa,":[673],"Samyukta":[674],"Chillara,":[675],"Mariana":[676],"Paes":[677],"Dias,":[678],"M.":[680],"Ferrero-Cafiero,":[681],"Aleix":[682],"Prat.":[683],"Primary":[684],"results":[685],"VALENTINE:":[688],"phase":[691],"trial":[693],"alone":[696],"combination":[699],"letrozole":[701],"hormone":[704],"receptor":[705],"positive":[706],"(HR+)/HER2-negative":[707],"(neg)":[708],"early":[709],"(EBC)":[712],"[abstract].":[713],"In:":[714],"Proceedings":[715],"San":[718,727],"Antonio":[719],"Breast":[720],"Cancer":[721,734],"Symposium":[722],"2024;":[723],"2024":[724],"Dec":[725],"10-13;":[726],"Antonio,":[728],"TX.":[729],"Philadelphia":[730],"(PA):":[731],"AACR;":[732],"Clin":[733],"Res":[735],"2025;31(12":[736],"Suppl):Abstract":[737],"nr":[738],"LB1-06.":[739]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2025-10-10T00:00:00"}